Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials
暂无分享,去创建一个
E. Dubberke | S. Khanna | R. Orenstein | P. Feuerstadt | T. Louie | Adam J Harvey | Christine Lee | Lindy L. Bancke | Beth Guthmueller